The prognostic effect on childhood acute lymphoblastic leukemia of CD34⁺CD38⁻ expressed in leukemia cells

References

• Wu C, Li W. Genomics and pharmacogenomics of pediatric acute lymphoblastic leukemia. Crit Rev Oncol Hematol. 2018;126:100–111. doi:10.1016/j.critrevonc.2018.04.002.
   PubMed Web of Science ®Google Scholar
• Inaba H, Pui CH. Immunotherapy in pediatric acute lymphoblastic leukemia. Cancer Metastasis Rev. 2019;38(4):595–610. doi:10.1007/s10555-019-09834-0.
   PubMed Web of Science ®Google Scholar
• Bhojwani D, Sposto R, Shah NN, et al. Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia [published correction appears in Leukemia]. Leukemia. 2019;33(4):884–892. doi:10.1038/s41375-018-0265-z.
   PubMed Web of Science ®Google Scholar
• Oskarsson T, Söderhäll S, Arvidson J, et al. Relapsed childhood acute lymphoblastic leukemia in the nordic countries: prognostic factors, treatment and outcome. Haematologica. 2016;101(1):68–76. doi:10.3324/haematol.2015.131680.
   PubMed Web of Science ®Google Scholar
• Vrooman LM, Silverman LB. Treatment of childhood acute lymphoblastic leukemia: prognostic factors and clinical advances. Curr Hematol Malig Rep. 2016;11(5):385–394. doi:10.1007/s11899-016-0337-y.
   PubMed Web of Science ®Google Scholar
• O'Connor D, Enshaei A, Bartram J, et al. Genotype-Specific minimal residual disease interpretation improves stratification in pediatric acute lymphoblastic leukemia. J Clin Oncol. 2018;36(1):34–43. doi:10.1200/JCO.2017.74.0449.
   PubMed Web of Science ®Google Scholar
• Lang F, Wojcik B, Bothur S, et al. Plastic CD34 and CD38 expression in adult B-cell precursor acute lymphoblastic leukemia explains ambiguity of leukemia-initiating stem cell populations. Leukemia. 2017;31(3):731–734. doi:10.1038/leu.2016.315.
   PubMed Web of Science ®Google Scholar
• Blatt K, Menzl I, Eisenwort G, et al. Phenotyping and target expression profiling of CD34+/CD38− and CD34+/CD38+ stem- and progenitor cells in acute lymphoblastic leukemia. Neoplasia. 2018;20(6):632–642. doi:10.1016/j.neo.2018.04.004.
   PubMed Web of Science ®Google Scholar
• Zeijlemaker W, Grob T, Meijer R, et al. CD34+CD38− leukemic stem cell frequency to predict outcome in acute myeloid leukemia. Leukemia. 2019;33(5):1102–1112. doi:10.1038/s41375-018-0326-3.
   PubMed Web of Science ®Google Scholar
• Herrmann H, Sadovnik I, Cerny-Reiterer S, et al. Dipeptidylpeptidase IV (CD26) defines leukemic stem cells (LSC) in chronic myeloid leukemia. Blood. 2014;123(25):3951–3962. doi:10.1182/blood-2013-10-536078.
   PubMed Web of Science ®Google Scholar
• Zeng H, Yin LD, Li P, et al. The level of peripheral blood circulating CD34+ cells is higher in acute promyelocytic leukemia patients with adverse prognostic factors. Hematology. 2016;21(9):513–519. doi:10.1080/10245332.2016.1150410.
   PubMed Web of Science ®Google Scholar
• Bürgler S, Gimeno A, Parente-Ribes A, et al. Chronic lymphocytic leukemia cells express CD38 in response to Th1 cell-derived IFN-γ by a T-bet-dependent mechanism. J Immunol. 2015;194(2):827–835. doi:10.4049/jimmunol.1401350.
   PubMed Web of Science ®Google Scholar
• Parker C, Waters R, Leighton C, et al. Effect of mitoxantrone on outcome of children with first relapse of acute lymphoblastic leukaemia (ALL R3): an open-label randomised trial. Lancet. 2010;376(9757):2009–2017. doi:10.1016/S0140-6736(10)62002-8.
   PubMed Web of Science ®Google Scholar
• Yu SL, Zhang H, Ho BC, et al. FPGS relapse-specific mutations in relapsed childhood acute lymphoblastic leukemia. Sci Rep. 2020;10(1):12074, doi:10.1038/s41598-020-69059-y.
   PubMed Web of Science ®Google Scholar
• Sidney LE, Branch MJ, Dunphy SE, et al. Concise review: evidence for CD34 as a common marker for diverse progenitors. Stem Cells. 2014;32(6):1380–1389. doi:10.1002/stem.1661.
   PubMed Web of Science ®Google Scholar
• van de Donk NW, Janmaat ML, Mutis T, et al. Monoclonal antibodies targeting CD38 in hematological malignancies and beyond. Immunol Rev. 2016;270(1):95–112. doi:10.1111/imr.12389.
   PubMed Web of Science ®Google Scholar
• Dakka N, Bellaoui H, Bouzid N, et al. CD10 and CD34 expression in childhood acute lymphoblastic leukemia in Morocco: clinical relevance and outcome. Pediatr Hematol Oncol. 2009;26(4):216–231. doi:10.1080/07357900902897557.
   PubMed Web of Science ®Google Scholar
• Gerby B, Clappier E, Armstrong F, et al. Expression of CD34 and CD7 on human T-cell acute lymphoblastic leukemia discriminates functionally heterogeneous cell populations. Leukemia. 2011;25(8):1249–1258. doi:10.1038/leu.2011.93.
   PubMed Web of Science ®Google Scholar
• Zeijlemaker W, Kelder A, Wouters R, et al. Absence of leukaemic CD34+ cells in acute myeloid leukaemia is of high prognostic value: a longstanding controversy deciphered. Br J Haematol. 2015;171(2):227–238. doi:10.1111/bjh.13572.
   PubMed Web of Science ®Google Scholar
• Sumide K, Matsuoka Y, Kawamura H, et al. A revised road map for the commitment of human cord blood CD34-negative hematopoietic stem cells. Nat Commun. 2018;9(1):2202, doi:10.1038/s41467-018-04441-z.
   PubMedGoogle Scholar
• Zhang YH, Yang L, Wang YZ, et al. In vitro identification and characteristics of CD34− leukemia stem cell in t(8;21) acute myeloid leukemia. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2017;25(5):1289–1294. doi:10.7534/j.issn.1009-2137.2017.05.003.
   PubMedGoogle Scholar
• Hadzijusufovic E, Keller A, Berger D, et al. STAT5 is expressed in CD34+/CD38− stem cells and serves as a potential molecular target in Ph-negative myeloproliferative neoplasms. Cancers (Basel). 2020;12(4):1021, doi:10.3390/cancers12041021.
   PubMed Web of Science ®Google Scholar
• Benedetto U, Head SJ, Angelini GD, et al. Statistical primer: propensity score matching and its alternatives. Eur J Cardiothorac Surg. 2018;53(6):1112–1117. doi:10.1093/ejcts/ezy167.
   PubMed Web of Science ®Google Scholar
• Guo J, Zheng P, Wang R, et al. Prognostic relevance of neuroendocrine differentiation in colorectal cancer: a population-based, propensity score matching study. Int J Colorectal Dis. 2020;35(12):2185–2195. doi:10.1007/s00384-020-03708-6.
   PubMed Web of Science ®Google Scholar